Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Jun 21:11:1219271.
doi: 10.3389/fpubh.2023.1219271. eCollection 2023.

Individual and mutual effects of diabetes, hypertension, and obesity on acute respiratory distress syndrome mortality rates in clinical patients: a multicentre study

Márcio Flávio Moura de Araújo  1 , Flávia Paula Magalhães Monteiro  2 , Thiago Moura de Araújo  2 , José Cláudio Garcia Lira Neto  1 , Lívia Fernanda Siqueira Santos  3 , Isaura Letícia Tavares Palmeira Rolim  3 , Floriacy Stabnow Santos  3 , Livia Maia Pascoal  3 , Ana Cristina Pereira de Jesus Costa  3 , Marcelino Santos Neto  3
Affiliations
Multicenter Study

Individual and mutual effects of diabetes, hypertension, and obesity on acute respiratory distress syndrome mortality rates in clinical patients: a multicentre study

Márcio Flávio Moura de Araújo et al. Front Public Health. .

Abstract

Patients with comorbidities are more vulnerable to severe clinical cases of acute respiratory distress syndrome (ARDS) and COVID-19 require complex health care. To analyse the association between the individual and combined effects of diabetes, hypertension, and obesity on ARDS mortality rates among patients receiving clinical care. A multicentre study encompassing retrospective data analysis and conducted with 21,121 patients from 6,723 health services across Brazil, during the 2020-2022 time period. The sample group consisted of clinical patients of both sexes and different age groups who received clinical care and showed at least one comorbidity. The data collected were analysed using binary logistic regressions and the Chi-square test. The overall mortality rate was 38.7%, with a higher predominance among males (p < 0.001), mixed-race individuals (p < 0.001), and older adults (p < 0.001). The main comorbidity variables associated with and leading to death from ARDS were arterial hypertension (p < 0.001), diabetes mellitus (p < 0.001), diabetes mellitus and arterial hypertension (p < 0.001), cardiovascular diseases (p < 0.001) and obesity (p < 0.001). Both the patients who progressed to recovery (48.4%) and to death (20.5%) presented only one comorbidity (χ2 (1,749) = 8, p < 0.001), respectively. The isolated comorbidities with the greatest impact on death outcomes were diabetes (95% CI 2.48-3.05, p < 0.001), followed by obesity (95% CI 1.85-2.41, p < 0.001) and hypertension (95% CI 1.05-1.22, p < 0.001), even after adjusting for sex and number of simultaneous comorbidities. Diabetes and obesity, as isolated conditions, had a greater influence on the number of deaths of clinical patients with ARDS compared to those with mutual diagnosis of diabetes, hypertension and obesity.

Keywords: COVID-19; comorbidity; diabetes; epidemiology; hypertension; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Distribution of the number of simultaneous comorbidities resulting in patient death by ADRS. Maranhão, Brazil, 2023.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ng WH, Tipih T, Makoah NA, Vermeulen JG, Goedhals D, Sempa JB, et al. . Comorbidities in SARS-CoV-2 patients: a systematic review and Meta-analysis. MBio. (2021) 12:e03647–20. doi: 10.1128/mBio.03647-20, PMID: - DOI - PMC - PubMed
    1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area [published correction appears in JAMA. 2020 may 26;323(20):2098]. JAMA. (2020) 323:2052–9. doi: 10.1001/jama.2020.6775, PMID: - DOI - PMC - PubMed
    1. Honardoost M, Janani L, Aghili R, Emami Z, Khamseh ME. The association between presence of comorbidities and COVID-19 severity: a systematic review and Meta-analysis. Cerebrovasc Dis. (2021) 50:132–40. doi: 10.1159/000513288, PMID: - DOI - PMC - PubMed
    1. Vulturar DM, Crivii CB, Orăsan OH, Palade E, Buzoianu AD, Zehan IG, et al. . Obesity impact on SARS-CoV-2 infection: pros and cons "obesity paradox"-a systematic review. J Clin Med. (2022) 11:3844. doi: 10.3390/jcm11133844, PMID: - DOI - PMC - PubMed
    1. Wang Z, Deng H, Ou C, Liang J, Wang Y, Jiang M, et al. . Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: a systematic review and meta-analysis without cases duplication. Medicine (Baltimore). (2020) 99:e23327. doi: 10.1097/MD.0000000000023327, PMID: - DOI - PMC - PubMed

Publication types